Live Quote · NASDAQREPLHealthcare· Biotechnology

Replimune Group, Inc.

$19.07▼ 0.83%($-0.16)
MKT CAP $1.81BNEXT EARNINGS Feb 2, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
40
Valuation
20
Profitability
15
Growth
80
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REPL research report →

Analyst Price Target
$24.75+29.8% vs. today

Range $19 – $31

Analyst RatingBuy
11 Buy3 Hold1 Sell

Price Chart

+111.65% · this period
$23.28$12.49$1.70Nov 20May 26Nov 20
52-Week Range80% of range
Low
$1.50
Current
$19.07
High
$23.54